The credit risk time bomb


Insurers’ foray into capital markets risk could cost them more than they ever bargained for. Regulatory bodies are nervously investigating insurers’ use of credit derivatives, while market participants are predicting serious losses from these instruments. Adding fuel to the fire, many insurers are now starting to contest payouts, and their reputation as competent financial services firms hangs in the balance.

Indeed, a group of 10 monoline insurers is currently contesting whether the debt r

To continue reading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: